Product Information
ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR is a generic product labeled by CELLTRION USA, Inc., priced at $494.1778 per EA under NDC 72606002210. Its NADAC has been published 19 times since Feb 18, 2026.
Manufacturer
CELLTRION USA, Inc.NDC
72606002210
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Biologic (BLA)
FDA Application
BLA761219On Market Since
11/30/2023
Price Statistics
The NADAC for ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR has been published 19 times since Feb 18, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $494.1778 per EA |
|---|---|
| All-time high | $495.3681 (Apr 15, 2026) |
| All-time low | $493.1540 (Feb 18, 2026) |
| 52-week high | $495.3681 |
| 52-week low | $493.1540 |
| Median price | $494.1981 |
| Average price | $494.3973 |
| Largest weekly change | +0.4% (Mar 18, 2026) |
| Weeks tracked | 19 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR, manufactured by CELLTRION USA, Inc., is $494.1778 per EA (NDC 72606002210), effective Jun 24, 2026.
How has the price of ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR has held within roughly two percent of its current level. It has been tracked across 19 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR?
Since Feb 18, 2026, the NADAC for ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR has ranged from a low of $493.1540 (Feb 18, 2026) to a high of $495.3681 (Apr 15, 2026), with a median of $494.1981 per EA.
Are there cheaper alternatives to ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR, but none are currently priced below it.
Who manufactures ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR?
ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR (NDC 72606002210) is labeled by CELLTRION USA, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification